Peripheral T-cell tolerance defined through transgenic mouse studies

Autoimmunity

Volumn 33, Issue 2, 2001, Pages 135-149

  Tindle, R W ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

CD8+ive T cell; Immunological tolerance; Immunoregulation; Transgenic mouse

Indexed keywords

CD8 ANTIGEN;

ANIMAL CELL; AUTOIMMUNITY; CELL ACTIVITY; CELL MATURATION; CELL POPULATION; CLONAL ANERGY; CROSS TOLERANCE; GENE DELETION; GENE EXPRESSION; GENETIC CODE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; REVIEW; THYMUS; TRANSGENIC MOUSE;

EID: 0035068019     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916930108995998     Document Type: Review

References (98)

1. In thymic selection, peptide diversity gives and takes away
2. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts
3. T cell selection in the thymus
4. T cell tolerance and autoimmunity
5. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex
6. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo
7. In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B
8. The V beta-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice
9. Superantigen-induced anergy in cytotoxic CD8+ T cells
10. The potential roles of endogenous retroviruses in autoimmunity
11. Mechanisms of tolerance to self
12. Recovery of myelin basic protein reactive T cells from spinal cords of Lewis rats with autoimmune encephalomyelitis
13. Specificity and T cell receptor beta chain usage of a human collagen type II-reactive T cell clone derived from a healthy individual
14. Low avidity recognition of self-antigen by T cells permits escape from central tolerance
15. Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles
16. Autoimmunity caused by ignorant CD8+ T cells is transient and depends on avidity
17. Induction of diabetes is influenced by the infectious virus and local epression of MHC class I and tumor necrosis factor-alpha
18. Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: Implications for tolerance and immunotherapy
19. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens
20. All or none peripheral tolerance induction in H-Y antigen-specific TCR transgenic mice
21. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen
22. Levels of peripheral T cell tolerance induced by different doses of tolerogen
23. T lymphocyte-mediated control of autoimmunity
24. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease
25. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death
26. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia
27. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver
28. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells
29. Lymphocyte homing and homeostasis
30. Naive and memory T cells show distinct pathways of lymphocyte recirculation
31. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
32. Constitutive class I-restricted exogenous presentation of self antigens in vivo
33. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity
34. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells
35. Cytotoxic T lymphocyte recognition of HLA-G in mice
36. CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
37. T cell tolerance and activation to a transgene-encoded tumor antigen
38. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes
39. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction
40. B cells directly tolerize CD8(+) T cells
41. B cells are not essential for peripheral T-cell tolerance
42. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
43. CD4+ T cells orchestrate both implication and deletion of CD8+ T cells
44. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
45. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis
46. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
47. Transactivation by AP-1 is a molecular target of T cell clonal anergy
48. "Anergy" of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype
49. Th2 cell clonal anergy as a consequence of partial activation
50. Antigen presentation by keratinocytes induces tolerance in human T cells
51. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen
52. Is CTLA-4 a master switch for peripheral T cell tolerance?
53. Cytotoxic T lmphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes
54. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen
55. Persistence of peptide-induced CD4+ T cell anergy in vitro
56. A functionally compromised intermediate in extrathymic CD8+ T cell deletion
57. The induction of peripheral tolerance by the chronic activation and deletion of CD4+V beta 5+ cells
58. Virus persistence in acutely infected immunucomponent mice by exhaustion of antiviral cytotoxic effector T cells
59. Peripheral clonal deletion of antiviral memory CD8+ T cells
60. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins
61. Inductive events in oral tolerance in the TCR transgenic adoptive transfer model
62. Molecular mechanisms underlying functional T-cell unresponsiveness
63. Autoimmune diabetes as a consequence of locally produced interleukin-2
64. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
65. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease
66. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated patients
67. Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens
68. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats
69. "Infectious" transplantation tolerance
70. Balancing the immune system for tolerance: A case for regulatory CD4 cells
71. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10
72. T-lymphocyte and cytokine-directed strategies for inhibiting skin allograft rejection in mice
73. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection
74. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8
75. T-cell tolerance and autoimmunity in transgenic model of central and peripheral tolerance
76. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium
77. Multiple levels of regulation for self-tolerance in beef insulin transgenic mice
78. Direct thymic involvement in anterior chamber-associated immune deviation: Evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice
79. Chronic modulation of the TCR repertoire in the lymphoid periphery
80. Alternative pathways for the selection of antigen-specific peripheral T cells
81. Differential requirements for survival and proliferation of CD8 naive or memory T cells
82. Peristence of memory CD8 T cells in MHC Class-1 deficient mice
83. Selecting and maintaining a diverse T-cell repertoire
84. A two-step model for the induction of organ-specific autoimmunity
85. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunophatology
86. Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes
87. Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice
88. Organ-specific disease provoked by systematic autoimmunity
89. Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells
90. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma
91. Dendritic cells: From ignored cells to major players in T-cell-mediated immunity
92. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans
93. Cross-presentation: A general mechanism for CTL immunity and tolerance
94. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system
95. Death by neglect as a deletional mechanism of peripheral tolerance
96. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction
97. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells
98. Non-deletional mechanisms of peripheral and central tolerance: Studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen